GSMA
9.2.2020 19:05:05 CET | Business Wire | Press release
The GSMA knows that the Coronavirus has created disruption, in particular for exhibitors and attendees from around the world, including the 5-6,000 (5-6%) who have historically attended from China. Our sympathy goes to all those affected. We are grateful for the preventative measures our Chinese exhibitors have put in place, notably ZTE and Huawei. Today, the GSMA is moving ahead as planned and will host MWC Barcelona 24-27 February 2020. While the GSMA confirm some large exhibitors have decided not to come to the show this year with others still contemplating next steps, we remain more than 2,800 exhibitors strong.
In addition to all of the health and safety measures put in place, the Spanish health authorities, Host City Partners, other relevant agencies and the GSMA are collaborating. The GSMA is seeking to reassure attendees and exhibitors that their health and safety are our paramount concern, by the following additional measures being put in place:
- All travellers from the Hubei province will not be permitted access to the event*
- All travellers who have been in China will need to demonstrate proof they have been outside of China 14 days prior to the event (passport stamp, health certificate)
- Temperature screening will be implemented
- Attendees will need to self-certify they have not been in contact with anyone infected.
While further planning is underway, we will continue to monitor the situation and will adapt our plans according to developments and advice we receive. We are contending with a constantly evolving situation, that will require fast adaptability.
Measures being implemented include:
- Increased cleaning and disinfection programme across all high-volume touchpoints, e.g. catering areas, surfaces, handrails, WCs, entrances/exits, public touch-screens, etc. along with the use of correct cleaning/sanitising materials and products
- Increased onsite medical support – doubled over last year
- Awareness campaign via online and onsite info-share and signage
- Availability of sanitising and disinfection materials for public use
- Awareness and training to all staff on standard personal preventative measures, e.g. personal hygiene, frequency of use of sanitising/disinfection products, etc.
- Advice to exhibitors on implementing effective cleaning and disinfection of stands, offices along with guidance on personal hygiene measures and common preventive behaviour
- Public health guidelines and advice communication to Barcelona hotels, public and private transport, restaurants and catering outlets, retail, etc.
- Installing new signage onsite reminding attendees of hygiene recommendations
- Implementing a microphone disinfecting and change protocol for all speakers
- Communicating advice to all attendees to adopt a ‘no-handshake policy’
- A 24-hour telephone Security and Medical service for all attendees, operational from 12th to 29th February 2020. This number appears on the back of badge holders, in the event App and on signage around the venue.
We understand that in a press conference on Friday 7 February Health Minister Alba Vergés explained that the region of Catalonia is not a public health risk zone. The Health Minister stated “The Catalan health system is prepared to detect and treat coronavirus, to give the most appropriate response, and this must be clear to those attending MWC Barcelona,” said Vergés.
In a similar vein, the Secretary of Public Health, Joan Guix, noted that Catalonia is used to continually welcoming thousands of visitors to the region and reiterated his confidence in the regions readiness and responsiveness. Guix outlined the measures that the Public Health Agency of Catalonia had put in place and that the Spanish Ministry of Health was in constant communication with all relevant bodies. These include the Directorate General of Tourism and Hotels, both public and private health centres, the Chinese consulate and with the GSMA.
Finally, the head of the Service of Preventive Medicine and Epidemiology of the Hospital Clínic de Barcelona, Antoni Trilla, emphasised that “we are not in an exceptional situation and our health system is ready”. The press release can be found here: https://govern.cat/salapremsa/notes-premsa/382568/verges-catalonia-is-prepared-to-detect-and-treat-novel-coronavirus
The GSMA strongly urges exhibitors and attendees to implement appropriate guidelines and protocols as suggested by the WHO and other health authorities to contain and mitigate against any further spread of the virus. The health and safety of our exhibitors, attendees and staff are of paramount importance.
Further updates from the GSMA, answers to the most frequently asked questions and an outline of the measures that have been implemented, are on our website and can be found on www.mwcbarcelona.com .
-ENDS-
Notes to Editors
*By event we mean that to cover MWC Barcelona, Four Years From Now (4YFN), xside and YoMo
Up-to-date WHO advice can be found here: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/technical-guidance and the most recent press release issued by WHO is here: https://www.who.int/news-room/detail/30-01-2020-statement-on-the-second-meeting-of-the-international-health-regulations-(2005)-emergency-committee-regarding-the-outbreak-of-novel-coronavirus-(2019-ncov) .
About the GSMA
The GSMA represents the interests of mobile operators worldwide, uniting more than 750 operators and nearly 400 companies in the broader mobile ecosystem, including handset and device makers, software companies, equipment providers and internet companies, as well as organisations in adjacent industry sectors. The GSMA also produces the industry-leading MWC events held annually in Barcelona, Shanghai and Los Angeles, as well as the Mobile 360 Series of regional conferences.
For more information, please visit the GSMA corporate website at www.gsma.com . Follow the GSMA on Twitter: @GSMA.
View source version on businesswire.com: https://www.businesswire.com/news/home/20200209005026/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Europe’s Largest Celebration of Irish Culture Arrives in Belfast2.8.2026 10:01:00 CEST | Press release
Fleadh Cheoil na hÉireann arrives in Belfast today (2 August), bringing eight days of traditional music, culture and celebration to the city, with organisers expecting up to 800,000 visitors over the course of the festival. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260729147569/en/ Belfast Fleadh - Maddens Bar accordian, guitar and fiddle player (Chris Heaney) One of Europe’s largest cultural events, Fleadh Cheoil na hÉireann is taking place in Belfast for the first time, transforming the city into a vibrant stage for Irish music, dance, language and culture. More than 200 events and 180 traditional music competitions are taking place across venues, streets and neighbourhoods throughout the week-long celebration. The landmark festival showcases the very best of Irish culture, with a packed programme of All-Ireland competitions, concerts, community events and performances from both established and emerging artists. As Ir
2PointZero Group Signals Global Scale With Revenue Surge to AED 21.9 Billion and Net Profit of AED 7.7 Billion in H1 202631.7.2026 13:42:00 CEST | Press release
Group revenue growth supported by stable gross profit margin of 29%, and adjusted EBITDA of AED 5.0 billionGlobal expansion milestones include the completed sale of TAQA stake, and the acquisition of Traverse Midstream Partners in North America, Baobab Group in Africa, and 60.8% of ISEM in ItalyTIME ranks the Group 36th on the World’s Growth Leaders list for 2026, highlighting market stability, operational scale and disciplined approach to capital 2PointZero Group (ADX: 2POINTZERO), a leading Abu Dhabi-based investment holding firm, announced its financial results for the first half of 2026, reporting revenue of AED 21.9 billion and delivering a Group Net Profit of AED 7.7 billion. This robust performance is reflected in the Group’s adjusted EBITDA, which reached AED 5.0 billion after excluding fair value changes and one-offs. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260731538982/en/ Samia Bouazza, CEO of 2PointZero (P
Datroway® Approved in the EU as Only TROP2 Directed Medicine with Overall Survival Benefit for the First-Line Treatment of Patients with Metastatic TNBC Who Are Not Candidates for Immunotherapy31.7.2026 08:30:00 CEST | Press release
Approval based on TROPION-Breast02 phase 3 trial results where Daiichi Sankyo and AstraZeneca’s Datroway showed a statistically significant and clinically meaningful improvement for the dual primary endpoints of overall survival and progression-free survival Datroway now approved for two breast cancer indications in the EU Datroway® (datopotamab deruxtecan) has been approved in the European Union (EU) as monotherapy for the first-line treatment of adult patients with unresectable or metastatic triple negative breast cancer (TNBC) who are not candidates for PD-1/PD-L1 inhibitor therapy. Datroway is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The approval by the European Commission follows the positive opinionof the Committee for Medicinal Products for Human Use of the European Medicines Agency and is based on result
Polpharma Biologics Announces FDA and EMA Acceptance for Review of PB016 Vedolizumab Biosimilar Candidate31.7.2026 08:30:00 CEST | Press release
Polpharma Biologics International AG today announces that the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have accepted for review the Biologics License Application (BLA) and Marketing Authorisation Application (MAA), respectively, for PB016, a proposed vedolizumab biosimilar candidate to Takeda’s reference product Entyvio®* (vedolizumab) lyophilized vial for intravenous (IV) administration for the treatment of adults with moderately to severely active ulcerative colitis and Crohn's disease. The BLA and MAA acceptances represent significant milestones in Polpharma Biologics' development program and underscore the company's commitment to advancing high-quality biosimilars and expanding global access to affordable biologic medicines. "FDA and EMA acceptances for review of our IV vedolizumab biosimilar candidate mark a major achievement for Polpharma Biologics and validate our deep scientific expertise in biosimilar development and manufacturing," said
SES: Disclosure of Share Buyback Transactions31.7.2026 07:30:00 CEST | Press release
In the time period from June 2, 2026 until and including June 23, 2026, a number of 213,167 shares were bought back within the framework of the share buyback of SES to meet obligations under SES’s Equity Based Compensation Plan (EBCP). Shares were bought back as follows: Day of purchase Aggregated volume in shares Daily weighted average acquisition price of shares (EUR) Market June 2, 2026 27,097 8.8727 DXE June 2, 2026 72,903 8.8556 ENX June 5, 2026 16,624 8.3723 DXE June 5, 2026 31,510 8.4266 ENX June 15, 2026 26,451 7.8423 XPAR June 17, 2026 26,812 7.3910 XPAR June 23, 2026 11,770 7.2200 XPAR The transactions in a detailed form are published on SES’s website: https://www.ses.com/investors/shareholder-information/share-buy-backs. Follow us on: Twitter | Facebook | YouTube | LinkedIn | Instagram Read our Blogs > Visit the Media Gallery > About SES At SES, we believe that space has the power to make a difference. That’s why we design space solutions that help governments protect, busin
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
